No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs.
Van Laethem K et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 2007